Clinical trial
Perifosine in Treating Patients With Advanced Solid Tumors
NCT00005794 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00005794 |
|---|---|
| Title | Perifosine in Treating Patients With Advanced Solid Tumors |
| Official title | A Phase I Trial of Perifosine on a Loading Dose/Maintenance Dose Schedule in Patients With Advanced Cancer |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | perifosine |
| Start date | Feb 1, 2000 |
| Completion | Jul 1, 2003 |
| First posted | Oct 8, 2003 |
| Last update posted | Dec 13, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: